Category: Healthcare
-
Date:
North America Diverticular Treatment Market to Surpass USD 1.9 Billion by 2031 Amid Rising GI Disorders
The North America diverticular treatment market was valued at USD 986.6 million in 2022 and is projected to surpass USD 1.9 billion…
-
Date:
Organ Transplant Rejection Medication Market to Surpass US$ 7.0 Billion by 2031 Driven by Rising Organ Transplant Procedures and Advancements in Immunosuppressive Therapies
The global organ transplant rejection medication market is witnessing steady growth, supported by the increasing number of organ transplant procedures and continuous…
-
Date:
U.S. Itchy Scalp Treatment Market to Reach USD 1.2 Billion by 2031 with Rising Demand for Therapeutic Haircare
The U.S. itchy scalp treatment market is experiencing steady growth due to rising awareness regarding scalp health, increasing prevalence of dandruff and…
-
Date:
U.S. Injectable Contraceptives Market to Surpass USD 339.6 Mn by 2031 Amid Rising Family Planning Awareness
The U.S. injectable contraceptives market is witnessing steady growth owing to rising awareness regarding reproductive health, increasing preference for long-acting reversible contraceptives…
-
Date:
U.S. Pruritus Treatment Market to Reach Over US$ 8.4 Billion by 2031, Driven by Rising Skin Disease Prevalence and Growing Adoption of Advanced Anti-Itch Therapies
U.S. Pruritus Treatment Market Overview Pruritus, commonly known as itching, is a common symptom associated with various skin disorders such as eczema,…
-
Date:
U.S. OTC Topical Antifungals Market to Surpass USD 1.8 Billion by 2031 Amid Rising Fungal Infection Cases and Growing Consumer Awareness
The U.S. OTC topical antifungals market is experiencing steady growth as rising prevalence of fungal skin infections, increasing consumer awareness regarding self-medication,…
-
Date:
Congestive Heart Failure Drugs Market to Surpass US$ 13.5 Billion by 2031 Driven by Rising Cardiovascular Disease Burden and Advancements in Heart Failure Therapies
The global congestive heart failure (CHF) drugs market is witnessing significant growth, supported by the increasing prevalence of cardiovascular diseases and growing…
-
Date:
Lipid-lowering Drugs Market to Surpass USD 42.5 Billion by 2031, Driven by Rising Cardiovascular Disease Burden | TMR
Lipid-lowering Drugs Market Overview Lipid-lowering drugs are medications used to reduce cholesterol and other lipid levels in the blood, thereby lowering the…
-
Date:
Global RAS-acting Agents Market to Surpass USD 13.4 Bn by 2031 Amid Strategic Advances by AstraZeneca and Boehringer Ingelheim
The global RAS-acting Agents Market was valued at USD 9.7 billion in 2022 and is projected to surpass USD 13.4 billion by…
-
Date:
Vasopressin Antagonists Market to Reach USD 2.7 Billion by 2031 Amid Rising Demand for Fluid Management Therapies
The global Vasopressin Antagonists Market is experiencing significant growth due to the rising prevalence of hyponatremia, heart failure, liver cirrhosis, and kidney-related…
Olivia
Carter
is a writer covering health, tech, lifestyle, and economic trends. She loves crafting engaging stories that inform and inspire readers.
